BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34088935)

  • 21. A Nomogram Predicting the Prognosis of Renal Cell Carcinoma Patients with Lung Metastases.
    Sheng X; Lu X; Wu J; Chen L; Cao H
    Biomed Res Int; 2021; 2021():6627562. PubMed ID: 33791367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study.
    Wang J; Yang Y; Pan J; Qiu Y; Shen S; Wang W
    Jpn J Clin Oncol; 2022 Apr; 52(4):353-361. PubMed ID: 35137118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
    Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
    Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.
    Kutikov A; Egleston BL; Wong YN; Uzzo RG
    J Clin Oncol; 2010 Jan; 28(2):311-7. PubMed ID: 19933918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
    Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
    Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.
    Zheng P; Lai C; Yang W; Guo J; Xiao S; Chen Z
    Scand J Gastroenterol; 2020 Feb; 55(2):202-208. PubMed ID: 32008420
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram.
    Xu YB; Liu H; Cao QH; Ji JL; Dong RR; Xu D
    Cancer Med; 2020 Jun; 9(12):4095-4106. PubMed ID: 32314546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients.
    Piccinelli ML; Barletta F; Tappero S; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Tian Z; Luzzago S; Mistretta FA; Ferro M; Saad F; Shariat SF; Ahyai S; Longo N; Tilki D; Chun FKH; Terrone C; Briganti A; de Cobelli O; Musi G; Karakiewicz PI
    Eur Urol Focus; 2023 Sep; 9(5):799-806. PubMed ID: 37024421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    Wang B; Wang S; Ren W
    BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time.
    Bianchi M; Becker A; Hansen J; Trinh QD; Tian Z; Abdollah F; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
    BJU Int; 2013 Jun; 111(8):E283-9. PubMed ID: 23714646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
    Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
    BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
    Zhang G; Wu B; Wang X; Li J
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Marconi L; de Bruijn R; van Werkhoven E; Beisland C; Fife K; Heidenreich A; Kapoor A; Karam J; Kauffmann C; Klatte T; Ljungberg B; Matin S; Sjoberg D; Staehler M; Stewart GD; Tanguay S; Uzzo R; Welsh S; Wood L; Wood C; Bex A
    World J Urol; 2018 Dec; 36(12):1973-1980. PubMed ID: 30069581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
    Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
    World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
    Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
    Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer.
    Larcher A; Trudeau V; Dell'Oglio P; Tian Z; Boehm K; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
    Urology; 2017 Apr; 102():130-137. PubMed ID: 27884597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
    Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
    J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
    Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
    Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
    Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.